Journal
CHEST
Volume 122, Issue 6, Pages 298S-301SPublisher
AMER COLL CHEST PHYSICIANS
DOI: 10.1378/chest.122.6_suppl.298S
Keywords
angiogenesis; chemokine; fibrosis
Categories
Funding
- NCI NIH HHS [P50 CA90388, CA87879] Funding Source: Medline
- NHLBI NIH HHS [HL66027, HL03906, HL04493, P01 HL67665] Funding Source: Medline
Ask authors/readers for more resources
Angiogenesis, defined as the growth of new capillaries from preexisting vessels, is a pervasive biological phenomenon that is at the core of many physiologic and pathologic processes. An opposing balance of angiogenic and angiostatic factors regulates angiogenesis. Examples of physiologic processes that depend on angiogenesis include embryogenesis, wound repair, and the ovarian/menstrual cycle. In contrast, chronic inflammation associated with chronic fibroproliferative disorders as well as growth and metastasis of solid tumors are associated with aberrant angiogenesis. CXC chemokines comprise a unique cytokine family that contains members that exhibit on a structural/functional basis either angiogenic or angiostatic biological activity. In this review, we will discuss the role of CXC chemokines and angiogenesis in pulmonary fibrosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available